Globus Medical GMED Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

FortiveFTV

——

Other financials

Income statement

See full

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

See full

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

See full

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation

See full

Market cap$10.76B+15.7%

Enterprise value$10.31B+15.6%

P/E18.3×-31.7×

P/S3.5×-0.2×

Profitability

See full

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

See full

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Globus Medical's share-based payment - unrecognized cost of nonvested awards?: Globus Medical (GMED) reported share-based payment - unrecognized cost of nonvested awards of $129.4M in Q1 2026.
How has Globus Medical's share-based payment - unrecognized cost of nonvested awards changed year-over-year?: Globus Medical's share-based payment - unrecognized cost of nonvested awards decreased by 0.9% year-over-year, from $130.6M to $129.4M.